The gene isolation and cloning methods used in recombinant DNA technology rely on the fact that the genes of all organisms, from bacteria through mammals, are based on a similar molecular organization.
Gene cloning requires cutting a DNA molecule apart, modifying and reassembling its fragments, and producing copies of the modified DNA, its mRNA, and its gene product.
The DNA molecule is cut apart by using a bacterial enzyme, called a restriction enzyme, that binds to DNA wherever a particular short sequence of base pairs is found and cleaves the molecule at a specific nucleotide site.
In this way, a long DNA molecule can be broken down into smaller, discrete fragments, one of which contains the gene of interest. Many restriction enzymes are commercially available that cut DNA at different recognition sites.
The fragments of DNA can then often be replicated through insertion into a unicellular organism, such as a bacterium.
To do this, a cloning vector such as a bacterial virus or a small DNA circle that is found in most bacteria, called a plasmid, is used.
Viral and plasmid vectors replicate autonomously in the host bacterial cell.
During gene cloning, a bacterial vector and the DNA fragment are mixed and joined by a special enzyme called a DNA ligase.
The recombinant vectors formed are then introduced into a suitable culture of bacteria, and the bacteria are allowed to replicate and express the recombinant vector gene.
While this method is a staple of many geneticists, the methods of recombinant DNA technology can also be used in the development of pharmaceuticals. For example, recombinant DNA technology is used in the manufacture of human insulin that is used to treat diabetes mellitus.